HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.

Abstract
Parathyroid carcinoma is rare and the associated hypercalcaemia is often resistant to all treatment. A case is described in which prolonged control of hypercalcaemia has been achieved by infrequent infusions of pamidronate despite continuing hypersecretion of parathyroid hormone.
AuthorsP G Newrick, G D Braatvedt, A J Webb, E Sheffield, R J Corrall
JournalPostgraduate medical journal (Postgrad Med J) Vol. 70 Issue 821 Pg. 231-2 (Mar 1994) ISSN: 0032-5473 [Print] England
PMID8183761 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Diphosphonates
  • Parathyroid Hormone
  • Pamidronate
  • Calcium
Topics
  • Calcium (blood)
  • Carcinoma (blood, complications)
  • Diphosphonates (therapeutic use)
  • Female
  • Humans
  • Hypercalcemia (drug therapy)
  • Middle Aged
  • Pamidronate
  • Parathyroid Hormone (blood)
  • Parathyroid Neoplasms (blood, complications)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: